INSERM (INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE);UNIVERSITE PIERRE ET MARIE CURIE (PARIS 6)
发明人:
Olivier TABARY,Florence SONNEVILLE
申请号：
US15739366
公开号：
US20200040332A1
申请日:
2016.07.01
申请国别(地区):
US
年份:
2020
代理人:
摘要：
The present invention relates to methods and pharmaceutical compositions for the treatment of cystic fibrosis. In particular, the present invention relates to a method of treating cystic fibrosis in a subject in need thereof comprising administering to the subject a therapeutically effective amount of a nucleic acid miR-9 inhibitor.
